Navigation Links
New Data to Support VELCADE(R) (Bortezomib) For Injection Based Therapies as Setting New Standards in The Care of Newly Diagnosed Patients With Multiple Myeloma
Date:11/26/2007

- Three large, randomized Phase III trials of VELCADE in front-line multiple myeloma to be featured as oral presentations at the American

Society of Hematology (ASH) Annual Meeting -

CAMBRIDGE, Mass., Nov. 26 /PRNewswire-FirstCall/ -- Millennium Pharmaceuticals, Inc. (Nasdaq: MLNM) today announced that new data from more than 130 abstracts of VELCADE clinical studies are scheduled to be featured at the 49th ASH Annual Meeting in Atlanta, Georgia, December 8-11, 2007. The data will highlight the significant efficacy of VELCADE in multiple myeloma (MM) and non-Hodgkin's lymphoma (NHL).

(Logo: http://www.newscom.com/cgi-bin/prnh/19991220/MLNMLOGO )

"VELCADE based therapies have unprecedented complete remission rates and survival benefits in multiple myeloma," said Nancy Simonian, M.D., Chief Medical Officer, Millennium. "Data to be presented at ASH from three large, randomized Phase III trials will support the expansion of our market-leading therapy into the front-line multiple myeloma setting."

Front-Line Multiple Myeloma

Data to be featured at ASH will continue to build on the growing body of evidence that supports the use of VELCADE in both newly diagnosed transplant and non-transplant patients. The data from a total of 20 Phase II and Phase III front-line studies will highlight the efficacy of VELCADE based therapies with consistently high CR and survival benefits. Phase III presentation highlights are scheduled to include:

-- A Phase III Study Comparing VELCADE, Melphalan and Prednisone (VMP)

with Melphalan Prednisone (MP) in Newly Diagnosed Multiple Myeloma
'/>"/>

SOURCE Millennium Pharmaceuticals, Inc.
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6

Related medicine technology :

1. New Study Supports Efficacy of Vagus Nerve Stimulation for Treatment-Resistant Depression
2. Cell Therapeutics, Inc. (CTI) Supports Panel Discussion on Women and Lung Cancer on Capitol Hill
3. EntreMed Raises $20 Million to Support Clinical Development Program
4. Interim Response and Safety Analyses Support Continuation of Allos Therapeutics Pivotal Phase 2 PROPEL Trial of PDX in Patients with Peripheral T-Cell Lymphoma
5. Survival Data in FDA Approval for ERBITUX(R) (Cetuximab) Supports use as a Single Agent in Patients with Advanced Colorectal Cancer
6. Isis Reports Preclinical Data Supporting Liver Safety of ISIS 301012
7. PDHI Launches ConXus Rewards, Announces Partnership With Hallmark Insights to Support Incentive-Driven Wellness Programs
8. PositiveFriends.com Launches STD Social Networking Site Balancing Dating with Online Support Features
9. Data Support use of SuperGens CLIMB Technology in Lead Development and Optimization
10. SAIC Awarded Malaria Vaccine Production Support Contract Extension by the National Institute of Allergy and Infectious Diseases
11. Consumer Advocates Support Patent Office on Stem Cell Patent Rejection
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/17/2013)... 17, 2013 Oramed Pharmaceuticals Inc. ... drug delivery systems, announced today that the United States ... Investigational New Drug application(IND) for ORMD-0801, its oral insulin ... the FDA clearance to proceed," stated Nadav ... is a major milestone for Oramed and we look ...
(Date:5/16/2013)... ZURICH , May 17, 2013 ... and Research (A*STAR) and Switzerland,s Cytos ... been dosed in a Phase 1 clinical trial with their ... virus-like particle (VLP) technology. In this first Phase 1 clinical ... and its potential to protect against H1N1 influenza infection will ...
(Date:5/16/2013)...  Nektar Therapeutics, (Nasdaq: NKTR ) President and ... is scheduled to present at the upcoming 2013 UBS Global ... the Sheraton New York Hotel on Tuesday, May 21, 2013 ... be accessible via a Webcast through a link posted in ... http://www.nektar.com . This Webcast will be available for replay ...
Breaking Medicine Technology:Oramed Receives FDA Clearance to Initiate Oral Insulin Trials in the U.S. 2Oramed Receives FDA Clearance to Initiate Oral Insulin Trials in the U.S. 3A*STAR and Cytos Bring Singapore's First Influenza Vaccine to Clinical Testing 2A*STAR and Cytos Bring Singapore's First Influenza Vaccine to Clinical Testing 3A*STAR and Cytos Bring Singapore's First Influenza Vaccine to Clinical Testing 4A*STAR and Cytos Bring Singapore's First Influenza Vaccine to Clinical Testing 5A*STAR and Cytos Bring Singapore's First Influenza Vaccine to Clinical Testing 6Nektar Therapeutics' President and CEO, Howard W. Robin, To Present at the 2013 UBS Global Healthcare Conference in New York City 2
(Date:5/18/2013)... May 18, 2013 MOOSGO.COM published an original ... This book features a group of artists who share their ... photographs, illustrations and paintings. Exclusively for iPad . ... including songs and videos that reflect the signature idiosyncrasy and ... at the Apple iBook Store and it includes a ...
(Date:5/18/2013)... Minn. -- Regular consumption of coffee is associated ... (PSC), an autoimmune liver disease, Mayo Clinic research ... Digestive Disease Week 2013 conference in Orlando, Fla. ... the bile ducts that results in inflammation and ... the liver, liver failure and biliary cancer. , ...
(Date:5/18/2013)... ground-breaking advance in colonoscopy technology signals the future ... at Digestive Disease Week (DDW). Additional research focuses ... and exploring safer methods for removing polyps. ... called a colonoscope to examine the colon. This ... to look for precancerous polyps called adenomas in ...
(Date:5/18/2013)... Coral Springs, FL (PRWEB) May 18, 2013 ... segment dedicated to the special places we call home. These ... found on maps. They are the locations where the people ... The first-rate show takes viewers off the highways and shares ... the best of both nations with an American sports and ...
(Date:5/18/2013)... May 18, 2013 After working diligently for ... SizeItUp formally announced the integration of the fitment specs ... Genesis is set to stun the automobile market with its ... Hyundai Genesis is marked as the latest entry in the ... vehicles lined up for the year 2013. , Aptly ...
Breaking Medicine News(10 mins):Health News:New Art Book for iPad: Tango Art 2Health News:New colonoscope provides ground-breaking view of colon 2Health News:New colonoscope provides ground-breaking view of colon 3Health News:New colonoscope provides ground-breaking view of colon 4Health News:Communities of Distinction TV Presents "A Place to Call Home" Segment 2Health News:Renowned Rim Fitments Provider SizeItUp Launched Database Integrations for the 2012 Hyundai Genesis 2
... continue volunteer relief project for one more month ... On Disaster,Response (HODR), a volunteer-driven 501(c) 3 nonprofit ... volunteer,project in Rayenda, Bangladesh to help those devastated ... Bangladesh in over 15 years, hit the,coastline November ...
... issues of transgender identities -- in the workplace and professional ... vocational counselors to not only treat but to act as ... in the workplace. , "One of the main points of ... be, as vocational psychologists or career counselors, working with transgender ...
... Choices ( http://www.nhs.uk ), the,digital ,front door, to ... aimed to,help people improve their fitness levels., ... http://www.nhs.uk/Livewell/fitness/Pages/fitnesshome.aspx ) enables users,to get the low down ... and,provides them with clinically approved guidance to help ...
... social cues may mimic those of people, scientists say ... have social lives, too, and watching how their brains ... social behavior and autism. , Little is known about ... it to manage behavior, notes a team of researchers ...
... 2008 In workplaces where nurses are bullied, the ... suffers, and the retention of quality nurses becomes difficult. ... Gynecologic, & Neonatal Nursing reviews the psychological and social ... for creating a respectful work environment. , More ...
... of World TB Day 2008 (March 24), the Infectious ... Association (HIVMA) are urging U.S. policymakers to step up ... the disease both at home and abroad. , With ... in detecting new cases on the decline, resources are ...
Cached Medicine News:Health News:Hands on Disaster Response Extends Cyclone Relief Project 2Health News:Counselors should target discrimination and be advocates for transgender clients 2Health News:Counselors should target discrimination and be advocates for transgender clients 3Health News:Monkey Brain Gives Clues to Human Interaction 2Health News:ID, HIV experts urge more resources for TB 2
... The E-Holder™ Platform is designed with ... E-Gel® 96 and E-Gel® 48 gel cassettes ... This allows reproducible placement and loading from ... to make adjustments to the robot loading ...
... electrophoresis into an automated, high-throughput operation with ... system is ideal for analyzing multiple PCR ... Fully automated, robot-compatible, and ready to put ... your high-throughput screening assignments as easy as ...
... the possibility of leakage around glued or bonded ... gel trays meaning you do no have to ... friendliness, the Primo tanks come with built-in leveling ... Gel Systems are designed to be durable and ...
... formed directly on the UV-transparent gel bed using ... it cools, or outside the unit using a ... 7.5cm wide 10cm long. Different colors are offered ... only). Combs and tape are not included. Gel ...
Medicine Products: